Top Abstract Purchase Related
Home
>
Node
>
Subnode

HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the Hemophilia Growth and Development Study

Nichols, S.; Mahoney, E.M.; Sirois, P.A.; Bordeaux, J.D.; Stehbens, J.A.; Loveland, K.A.; Amodei, N.

Journal of Pediatric Psychology 25(8): 545-556

2000

ISSN/ISBN: 0146-8693
PMID: 11085758
DOI: 10.1093/jpepsy/25.8.545
Document Number: 342804
To assess changes in adaptive, emotional, and behavioral functioning over four years in children and adolescents with hemophilia and with or without HIV infection and to evaluate the relationship of these changes to immune status. Participants were 277 HIV-seropositive and 126 HIV-seronegative boys with hemophilia. Participants with HIV infection were divided into three groups based on trajectory of immune functioning (CD4+ cell counts) over the course of the study. Caregivers completed the Vineland Adaptive Behavior Scales and Pediatric Behavior Scale (PBS). Results showed declining Vineland Communication scores for participants with consistently poor immune functioning. These participants also started with more PBS Attention Deficit and Deviation symptoms, which then decreased more sharply than for other groups. Low CD4+ counts were consistently associated with more Health and Depression-Anxiety symptoms on the PBS. However, with few exceptions, group means remained within normal limits. According to their caregivers, boys with hemophilia and HIV infection showed considerable resilience with regard to adaptive behavior and emotional and behavioral problems. However, over time changes occurred in these areas that appear to be related to immune functioning.

Document emailed within 0-6 h
Secure & encrypted payments

Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Kaufman, F.; Gertner, J.; Sleeper, L.; Donfield, S.; Willis, B. 1993: Growth hormone secretion in HIV positive vs HIV negative hemophilic males with abnormal growth and pubertal development The Hemophilia Growth and Development Study Pediatric Research 33(4 Part 2): 80A
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Jones, P. 1979: Organization of hemophilia therapy. the role of the hemophilia center Sangre 24(5-C): 998-1004
Girolami, A.; Dal Bo Zanon, R.; Procidano, M. 1981: Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1 Folia Haematologica 108(6): 863-871
Magallón Martínez, M.; Ortega, F.; Pinilla, J. 1992: AIDS and hemophilia: experience in the La Paz Hemophilia Center Haemostasis 22(5): 281-292
Walker, I.; Poon, M.C. 1992: Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group Lancet 339(8784): 61-62
Haugaard, J.J. 2004: Recognizing and treating rare behavioral and emotional disorders in children and adolescents who have been severely maltreated: schizophrenia Child Maltreatment 9(2): 161-168
Haugaard, J.J. 2004: Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated: introduction Child Maltreatment 9(2): 123-130
Ingerslev, J.; Christiansen, S.E.; Kristensen, T.; Wallevik, K.; Bernvil, S.S. 1985: Treatment of hemophilia a and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP Ugeskrift for Laeger 147(45): 3592-3594
Sergis-Deavenport, E.; Varni, J.W. 1982: Behavioral techniques in teaching hemophilia factor replacement procedures to families Pediatric Nursing 8(6): 416-419
Haugaard, J.J.; Hazan, C. 2004: Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated: reactive attachment disorder Child Maltreatment 9(2): 154-160
Haugaard, J.J. 2004: Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated: borderline personality disorder Child Maltreatment 9(2): 139-145
Haugaard, J.J. 2004: Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated: dissociative disorders Child Maltreatment 9(2): 146-153
Haugaard, J.J. 2004: Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated: bipolar disorders Child Maltreatment 9(2): 131-138
Haugaard, J.J. 2004: Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated: somatization and other somatoform disorders Child Maltreatment 9(2): 169-176
Overby, K.J.; Lo, B.; Litt, I.F. 1989: Knowledge and concerns about acquired immunodeficiency syndrome and their relationship to behavior among adolescents with hemophilia Pediatrics 83(2): 204-210